Company intelligence / Profile preview

Capitainer

Stockholm, Sweden

Ownership: Private
Employees: ~16
Development stage: Other

Overview

Capitainer is a commercial-stage Swedish medtech company offering CE-marked volumetric microsampling cards for self-sampling of blood, plasma, urine and other fluids, validated in multiple clinical and research settings including kidney transplant monitoring, diabetes, thyroid disease and prostate cancer screening, with performance comparable to conventional venous sampling and pipetting methods.[1][3][5][8]

Therapeutic areas: NephrologyOtherEndocrinologyPsychiatryRare DiseasesOncology
Modalities: DeviceNon-pharmacological therapy
Industry: Consumable Medical Devices

Partnerships

Several Swedish healthcare regions for decentralized, at-home sampling in diabetes, thyroid disease and prostate cancer detection[3]Oslo University Hospital for clinical validation in kidney transplant recipients[5]

Beyond the preview

Go deeper on Capitainer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capitainer.

Explore the full profile